Correlation Between Brpr Corporate and Bristol Myers

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Brpr Corporate and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brpr Corporate and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Brpr Corporate Offices and Bristol Myers Squibb, you can compare the effects of market volatilities on Brpr Corporate and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brpr Corporate with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brpr Corporate and Bristol Myers.

Diversification Opportunities for Brpr Corporate and Bristol Myers

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Brpr and Bristol is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Brpr Corporate Offices and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Brpr Corporate is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brpr Corporate Offices are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Brpr Corporate i.e., Brpr Corporate and Bristol Myers go up and down completely randomly.

Pair Corralation between Brpr Corporate and Bristol Myers

Assuming the 90 days trading horizon Brpr Corporate Offices is expected to under-perform the Bristol Myers. But the stock apears to be less risky and, when comparing its historical volatility, Brpr Corporate Offices is 1.89 times less risky than Bristol Myers. The stock trades about -0.05 of its potential returns per unit of risk. The Bristol Myers Squibb is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  32,462  in Bristol Myers Squibb on August 31, 2024 and sell it today you would earn a total of  2,188  from holding Bristol Myers Squibb or generate 6.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy82.8%
ValuesDaily Returns

Brpr Corporate Offices  vs.  Bristol Myers Squibb

 Performance 
       Timeline  
Brpr Corporate Offices 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Brpr Corporate Offices are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Brpr Corporate is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Bristol Myers Squibb 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Bristol Myers sustained solid returns over the last few months and may actually be approaching a breakup point.

Brpr Corporate and Bristol Myers Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Brpr Corporate and Bristol Myers

The main advantage of trading using opposite Brpr Corporate and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brpr Corporate position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.
The idea behind Brpr Corporate Offices and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing